|
Pfizer-BioNTech Ask
to Expand COVID-19
Vaccine EUA to Those
Aged 12 to 15 Years
|
|
If the FDA administration agrees to an expansion of the emergency-use authorization (EUA) for the Pfizer-BioNTech vaccine, pharmacists likely will face an influx of younger teenagers seeking protection against COVID-19. The request is to include youths aged 12 to 15 years in the EUA, which now starts at age 16. Very positive trials are working in the companies’ favor. Here are more details.
|
|
|
UTI Antibiotic Prescribing Improving but Still Often
Guideline-Discordant
|
|
|
The good news is that antibiotic prescribing appears to be getting better for uncomplicated urinary tract infections (UTIs). The bad news is that inappropriate antibiotics are often still used to treat the common conditions. Find out what has changed, including which other antibiotics are increasing in use for uncomplicated UTIs.
|
|
More Evidence That One mRNA Vaccine Dose Will Suffice in COVID-19 Survivors
|
|
|
Anecdotal reports suggest that patients who recovered from COVID-19 are having strong responses to the first mRNA vaccines. Now, a new study confirms that and suggests that a second dose of the Pfizer-BioNTech vaccine might not be necessary because recovered patients are generating an immunologic response similar to those who have never been infected and are receiving the two-dose recommend sequence. Here is more information.
|
|
|
With Lack of Official Guidance, How to Advise on
Vitamin D Supplementation
|
|
Drugstores are a popular place to purchase vitamin D supplements and, as a result, pharmacists field a lot of questions on the topic. But what advice can be offered when recommendations and guidelines are so inconclusive? Find out what an accompanying commentary recommends based on yet another indecisive U.S. Preventive Services Task Force report on vitamin D.
|
|
